Loading...

SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer

Immunotherapeutic strategies including the blockade of programmed death 1 (PD-1) receptors hold promise for the treatment of various cancers including non-small cell lung carcinoma (NSCLC). Preclinical data suggest that pre-existing tumor immunity is important for disease regression upon checkpoint...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Dhodapkar, Kavita M, Gettinger, Scott N, Das, Rituparna, Zebroski, Henry, Dhodapkar, Madhav V
Format: Artigo
Sprog:Inglês
Udgivet: Landes Bioscience 2013
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3782159/
https://ncbi.nlm.nih.gov/pubmed/24073380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.25205
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!